This website requires certain cookies to work and uses other cookies to help you have the best experience. By visiting this website, certain cookies have already been set, which you may delete and block. By closing this message or continuing to use our site, you agree to the use of cookies. Visit our updated privacy and cookie policy to learn more.
This Website Uses Cookies By closing this message or continuing to use our site, you agree to our cookie policy. Learn MoreThis website requires certain cookies to work and uses other cookies to help you have the best experience. By visiting this website, certain cookies have already been set, which you may delete and block. By closing this message or continuing to use our site, you agree to the use of cookies. Visit our updated privacy and cookie policy to learn more.
A therapeutic agent against osteoarthritis is now available. The Bioactive Collagen Peptides™ of FORTIGEL®, from GELITA, specifically stimulate cartilage metabolism and enhance the synthesis of cartilage cells. In this way, FORTIGEL is a new and promising agent counteracting the progressive loss of cartilage tissue. The effect in treatment of degenerative joint diseases has been confirmed in numerous international preclinical and clinical studies. GELITA AG, Eberbach, Germany, +49 6271 84 2194, www.GELITA.com
A recent clinical study, published in the open-access journal Nutrition & Metabolism, shows a weight-management solution that reduces body fat and retains lean muscle. Prolibra® Weight Management Solution improved body composition by significantly reducing body fat, while retaining lean muscle mass. Prolibra is a patent-pending, all-natural, specialized whey fraction developed by Glanbia Nutritionals as a healthy solution to weight loss. Applications include nutrition bars, RTD beverages, powdered beverages, fruit beverages and smoothies, dairy beverages and snacks. The full study is available at: www.glanbianutritionals.com